MedTrace Logo

Anosmia and Covid-19

NCT05246059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2022-02-18

No results posted yet for this study

Summary

Our study aims to determine the prevalence of anosmia in patients SARS-Cov-2/Covid-19 infection (both by symptom reporting and smell testing), the efficacy of early olfactory training for the treatment of anosmia caused by infection and the long-term impact of smell dysfunction with a one-year follow-up.

Conditions

  • Anosmia
  • SARS CoV 2 Infection

Interventions

OTHER

Olfactory Training

Sniffin' Sticks (Duft-Quartett, Burghart Messtechnik, GmbH, Germany)

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Valerie J. Lund, MD FRCS · University College, London

  • Matt Lechner, MD FRCS · University College London, Barts Health NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2021-08-08
Completion
2021-08-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05246059 on ClinicalTrials.gov